Bangladesh
· Delayed Price · Currency is BDT Pharma Aids Statistics
Total Valuation
Pharma Aids has a market cap or net worth of BDT 2.25 billion. The enterprise value is 2.20 billion.
| Market Cap | 2.25B |
| Enterprise Value | 2.20B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharma Aids has 3.12 million shares outstanding.
| Shares Outstanding | 3.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.57% |
| Owned by Institutions (%) | n/a |
| Float | 2.36M |
Valuation Ratios
The trailing PE ratio is 44.27.
| PE Ratio | 44.27 |
| Forward PE | n/a |
| PS Ratio | 5.49 |
| PB Ratio | 6.63 |
| P/FCF Ratio | 80.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.42, with an EV/FCF ratio of 78.84.
| EV / Earnings | 43.36 |
| EV / Sales | 5.38 |
| EV / EBITDA | 26.42 |
| EV / EBIT | 28.89 |
| EV / FCF | 78.84 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 1.14.
| Current Ratio | 3.36 |
| Quick Ratio | 1.95 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.14 |
| Interest Coverage | 285.13 |
Financial Efficiency
Return on equity (ROE) is 16.10% and return on invested capital (ROIC) is 14.58%.
| Return on Equity (ROE) | 16.10% |
| Return on Assets (ROA) | 11.26% |
| Return on Capital (ROIC) | 14.58% |
| Revenue Per Employee | 5.18M |
| Profits Per Employee | 642,467 |
| Employee Count | 79 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 5.39 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.92% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -8.92% |
| 50-Day Moving Average | 688.06 |
| 200-Day Moving Average | 707.71 |
| Relative Strength Index (RSI) | 58.66 |
| Average Volume (20 Days) | 26,724 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Aids had revenue of BDT 408.99 million and earned 50.75 million in profits. Earnings per share was 16.27.
| Revenue | 408.99M |
| Gross Profit | 120.73M |
| Operating Income | 76.18M |
| Pretax Income | 75.82M |
| Net Income | 50.75M |
| EBITDA | 83.30M |
| EBIT | 76.18M |
| Earnings Per Share (EPS) | 16.27 |
Balance Sheet
The company has 50.15 million in cash and 3.87 million in debt, giving a net cash position of 46.28 million or 14.83 per share.
| Cash & Cash Equivalents | 50.15M |
| Total Debt | 3.87M |
| Net Cash | 46.28M |
| Net Cash Per Share | 14.83 |
| Equity (Book Value) | 338.96M |
| Book Value Per Share | 108.64 |
| Working Capital | 277.33M |
Cash Flow
In the last 12 months, operating cash flow was 30.02 million and capital expenditures -2.11 million, giving a free cash flow of 27.91 million.
| Operating Cash Flow | 30.02M |
| Capital Expenditures | -2.11M |
| Free Cash Flow | 27.91M |
| FCF Per Share | 8.95 |
Margins
Gross margin is 29.52%, with operating and profit margins of 18.63% and 12.41%.
| Gross Margin | 29.52% |
| Operating Margin | 18.63% |
| Pretax Margin | 18.54% |
| Profit Margin | 12.41% |
| EBITDA Margin | 20.37% |
| EBIT Margin | 18.63% |
| FCF Margin | 6.82% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.14%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | -80.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.15% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.14% |
| Earnings Yield | 2.26% |
| FCF Yield | 1.24% |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |